Perbedaan UBC Medical Indonesia Tbk. dan Surya Biru Murni Acetylene Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp148 (kapitalisasi pasar 576,7 M, volume 24 jam 3,48 jt), sedangkan Surya Biru Murni Acetylene Tbk. diperdagangkan di Rp108 (kapitalisasi pasar 98,57 M, volume 24 jam 330,2 rb). Perbedaan utamanya: UBC Medical Indonesia Tbk. jauh lebih besar — sekitar 5,9× kapitalisasi pasar Surya Biru Murni Acetylene Tbk., dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (3,48 jt vs 330,2 rb). Mana yang lebih baik tergantung tujuan investasimu.
| LABS | SBMA | |
|---|---|---|
Kapitalisasi Pasar | 576,7 M | 98,57 M |
Volume | 3,48 jt | 330,2 rb |
Lot | 34,82 rb | 3,3 rb |
Perputaran | 522,79 jt | 35,06 jt |
Harga Rata-rata | 150,13 | 106,16 |
Nilai Transaksi | 522,79 jt | 35,06 jt |
Harga Ekuilibrium Indikatif | 148 | — |
Volume Ekuilibrium Indikatif | 350 | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →PT Surya Biru Murni Acetylene Tbk (the Company) was established in Balikpapan based on Notarial Deed No. 57 of Mohamad Rasjid Umar, S.H., dated October 25, 1980. The Company started its commercial operations in 1982.
Selengkapnya di halaman SBMA →